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ABSTRACT 
Background: Aneurysmal regression is a reliable marker for long-lasting success, following 
endovascular aneurysm repair (EVAR). The aim of this study is to identify the preoperative 
factors which can predictably lead to aneurysmal sac regression following EVAR, according 
to the reporting standards of the Society of Vascular Surgery and the International Society of 
Vascular Surgery (IVS/ISCVS).  
Methods: From a total of 199 patients treated by EVAR between 2000 and 2009, 164 
completed computerized tomography angiographies (CTA) and duplex scan follow-ups. 
Moreover, for any patient to be enrolled in this retrospective study, all of his/her CTAs were 
required to be analyzable with Endosize software (Therenva®, Rennes, France), in order to 
provide spatially correct three-dimensional data in accordance with the recommendations of 
the IVS/ISCVS. All anatomic parameters were graded according to the relevant severity 
grades. From these grades, a severity score was calculated at the aortic neck, the AAA and the 
iliac arteries. Clinical and demographic factors were also studied. Patients with aneurysmal 
regression > 5 mm were assigned to group A, and the others were assigned to group B. 
Results: Aneurysmal regression occurred in 66 (40.2%) patients (group A). The mean age 
was 71.4 ± 8.9 years in group A, and 76.3 ± 8.3 in group B. Univariate analyses showed 
smaller severity scores at the aortic neck (p=0.02) and the iliac arteries (p=0.002) in group A. 
In group A, calcifications and thrombus were less significant at the aortic neck (p=0.003 and 
p=0.02) and at the iliac arteries (p=0.001 et p=0.02), and inferior mesenteric artery patency 
was less frequent (68.2% vs 82.7%, p=0.04). Two multivariate analyses were carried out, of 
which one considered the scores, and the other was based on the variables included in the 
scores. In the first, the patients of group A were younger (p=0.002) and aortic neck 
calcifications were less significant (p=0.007). In the second, the patients of group A were 
younger (p<0.001) and the aortic neck scores were smaller (p=0.04). There was no difference 
between the two groups, in terms of the implanted endoprosthesis, nor in the follow-up 
(46.4 ± 24 months in group A, and 47.2 ± 22 months in group B, p=0.35). 
Conclusion: In this study, the young age of the patients and their aortic neck quality, in 
particular the absence of neck calcification, appear to have been the main factors affecting 
aneurysm regression, such that they represent a target population for the improvement of 
EVAR results.  
INTRODUCTION 
Endovascular aneurysm repair (EVAR) of an abdominal aortic aneurysm (AAA) does not 
systematically lead to regression of the AAA sac
1
. However, such regression is a reliable 
marker for long-term success
2-6
. Regression of the sac is, in particular, a marker for the 
absence of further surgery, and for the absence of rupture during follow-up. In order to 
improve the results achieved with EVAR, it would seem logical to try to identify any 
predictive factors for sac regression. The role of prostheses has been incriminated, particularly 
in the case of first generation prostheses
7-12
. Anatomic factors were also studied. It appears 
that less favorable anatomies lead to poorer results
13, 14
. However, in most studies the 
description of these anatomic factors does not comply with the reporting standards
15
, the 
publishing of which was intended to standardize the outcomes of studies dealing with 
EVARs. This description has the advantage of analyzing a large number of anatomic factors, 
and of providing a sufficient level of detail. An exhaustive and more accurate description of 
these factors, in patients presenting with AAA regression, would perhaps also allow EVAR 
candidates to be more rigorously selected. The aim of the present study was to identify the 
preoperative clinical and anatomic factors, which are predictive of aneurysmal regression 
following EVAR, in accordance with the recognized reporting standard.  
MATERIAL AND METHODS 
From a total of 199 consecutive patients operated in our unit for an infrarenal AAA, between 
January 2000 and December 2009, 164 were included in the retrospective study. Image 
analysis was carried out using the Endosize
16
 software (Therenva®, Rennes, France). It was 
thus possible to make 3D angular measurements and to compute the tortuosity indices 
according to the reporting standards' recommendations. Whenever the preoperative CT image 
could not be analyzed with this software, it was consequently not possible to carry out all of 
the measurements according to the reporting standards, and these patients were excluded from 
the study. If the follow-up was incomplete, the patients were also excluded. Finally, 164 
patients (147 men, 17 women) could be included in this analysis and in total, 164 aortic necks 
and aneurysms and 327 iliac arteries were analyzed (one patient had a single iliac occlusion). 
The patients were operated on using the endovascular technique, whenever they were not 
eligible for open repair
17
 and whenever the aneurysm diameter was greater than 50 mm, or if 
its growth rate was greater than 1 cm per year, or if it was painful. Infected, inflamed and 
ruptured aneurysms were excluded, as were patients operated with a fenestrated or branched 
endoprosthesis. A preoperative CT angiography was required before surgery, and at 1, 6, 12, 
18 and 24 months of follow-up, after the operation. The patients were then followed-up, with 
images being taken every year, alternately by CT angiography or ultrasonography. For the 
purposes of the study, the time interval between the last CT image and the operation was 
taken to represent the follow-up duration of each patient. The mean interval was 46.8 ± 22.6 
months (minimum 18 months; maximum 120 months).  
Anatomic factors. All of the measurements were made perpendicularly to the centerlines, 
which were extracted automatically (Fig. 1). For the preoperative scan, in addition to the 
measurements generally required before ordering an endograft, other parameters were 
measured and sorted according to the reporting standards
15
. The maximum AAA diameter 
was always measured at the same cutting level for all of the scans. Each anatomic parameter 
was classed according to four grades of severity, from which three anatomic severity scores 
were computed (Table 1). The aortic neck score was the sum of the grades determined for the 
thrombus, diameter, length, calcifications, and aortic neck angulation. The AAA score was 
the sum of the grades determined for the thrombus, the angle, and the T1 ratio (tortuosity 
index of the aorta, i.e. the ratio of the length of the aorta from the renal arteries to the aortic 
bifurcation, taken along the central line, to the length of a straight line between these points) 
of the AAA collaterals. The iliac score was the sum of the diameter grades, the length, the T2 
ratio (Fig. 1) (tortuosity index of the iliac axis, taken from the aortic bifurcation to the 
common femoral artery, computed as for the aortic index), the thrombus, the calcifications 
and the minimum diameter of the iliac axes.  
Non-anatomic factors. In addition to the anatomic parameters, the clinical factors (Table 2), 
follow-up duration, type of implanted endoprosthesis, and installation (aorto-bi-iliac or uni-
iliac) were considered. The patients' clinical factors were classed according to the 
recommendations
15
 (Table 2) 
Sub group. Group A was comprised of patients who, during follow-up, presented with 
> 5 mm
2, 15, 18
 regression of the aneurysmal sac. The remaining patients were assigned to 
group B.  
Statistical Analysis. The data is presented in the form of mean ± standard deviation for 
quantitative variables, unless otherwise noted, and in the form of numbers with corresponding 
percentages for qualitative variables. The predictive factors (clinical and anatomical) for sac 
regression were studied using univariate analyses, which were computed using the Kaplan-
Meier method and the log-rank test, since the follow up dates were not the same for all 
patients. Anatomic severity scores were considered as ordinal variables and compared with 
the Mann-Whitney test. Variables found to be less than 0.1 in the univariate analysis were 
included in a multivariate analysis, implemented using a Cox model. A stepwise descending 
procedure was carried out. Two multivariate analyses were carried out, with the variables 
considered separately or grouped together in scores. We checked the PH assumption for all 
covariates of the two models using a graphical approach, by plotting the logarithms of the 
cumulative probabilities. Between endografts, the rate of regression was compared using the 
Fischer exact test. The rate of endoleaks between group A and B, as the comparison of the 
anatomic factors related to endoleaks were also computed using the Kaplan-Meier analysis 
and the log-rank rank test. Correlation between age and the evolution of the maximum AAA 
diameter was assessed with the Pearson correlation coefficient. All analyses were performed 
with the Statistica software 6.0 version (Statsoft, Oklahoma, USA), and the statistical level of 
significance was 5%. 
RESULTS 
Demographics. The clinical characteristics of the studied population are provided in Table 3. 
The regression rate in the present study was 40.2% (group A, n=66). The regression>5 mm of 
the AAA was observed on the postoperative CTA at 15.9 ± 10 months. Using univariate 
analysis, age was the only significant factor (Table 1, P < 0.001). The Kaplan-Meier curves 
showed that there is a significant difference in regression rate (P=0.005) between the four age 
severity grades (Fig. 2) (Table 3). Regression occurred most frequently when the patients' age 
corresponded to grade 1 (between 55 and 70 years the regression rate was 58%). For the other 
patients, this rate was 33% for those in grade 0, 46% in grade 2, and 23% for those in grade 3. 
The postoperative variation of the AAA diameter was found to be correlated with age (Fig. 3) 
(P=0.001).  
Anatomic factors. The anatomic descriptions are summarized in Table 3.. Concerning the 
aortic neck, calcifications and thrombus were less severe in group A (P=0.003 and P=0.02, 
respectively). The best regression rate for aortic neck calcifications and thrombus 
corresponded to grade 0 (51% and 49% respectively). Similarly, the severity score for the 
aortic neck was lower in group A (Table 4) (3.5 ± 2.3 in group A and 4.4 ± 2.5 in group B, 
P=0.05). For the AAA score, as well as for all of the parameters used to establish this score, 
there was no significant difference between the groups. When the inferior mesenteric artery 
(IMA) was considered as a separate variable (not included in the aortic branches) the patency 
of the inferior mesenteric artery (IMA) was lower in group A (P=0.04). In the case of the iliac 
arteries, calcifications and thrombus were less severe in group A (P=0.001 and P=0.02, 
respectively). The severity score for the iliac arteries was lower for group A (6.5 ± 2.1 in 
group A and 7.7 ± 2.3 in group B, P=0.002).  
Non anatomic factors. The implanted endoprosthesis distribution is summarized in Table 5. 
There was no significant difference between the implanted prostheses in the two groups 
(P=0.40). Seven (10.6%) aorto-uni-iliac endoprostheses were implanted in group A, and 15 
(15.3%) in group B (P=0.47). The follow-up duration was 46.4 ± 24 months in group A and 
47.2 ± 22 months in group B (P=0.35).  
Multivariate analysis. In the first multivariate analysis, the age was lower in group A 
(P=0.002) and aortic neck calcifications were less severe (P=0.007). The hazard ratios (HR) 
and 95% confidence intervals (CI) were 0.96 (95% CI: 0.94-0.98) for age and 0.60 (95% CI: 
0.41-0.87) for aortic neck calcifications. In the second analysis, the patients were also 
younger in group A (HR 0.96 [95% CI: 0.94-0.98], P<0.001) and the aortic neck score was 
lower (HR 0.87 [95% CI: 0.78-0.97], P=0.04).  
Postoperative follow-up 
Group A was associated with a lower rate of all types of endoleak (Table 6). The occurrence 
of a type Ia endoleak during follow up was associated with a higher preoperative aortic neck 
severity score (Table 7). Variables at the aortic neck which were significantly more severe 
among patients with a type Ia endoleak during follow-up were thrombus (P=0.01) and 
calcifications (P=0.01). The occurrence of a type Ib endoleak during follow up was associated 
with more complex iliac anatomies especially in terms of angle, tortuosity index, 
calcifications and thrombus (Table 8). Patients with a type Ib endoleak had a lower iliac 
severity score than the others (P=0.001) (Table 8). No difference was found in the aneurysm 
related factors between patients with a type II endoleak during follow-up and others patients. 
When the IMA was considered as a separate variable, the rate of IMA patency was higher 
among patients with a type II endoleak (P=0.008).    
DISCUSSION 
Reporting standards have been published, with a view to normalizing EVAR-related data and 
allowing studies to be compared. Indeed, the description of calcifications or thrombus on the 
aortic neck varies widely from one study to another. It can be limited to a binary 
quantification (present or absent) or, at the other extreme, be segmented with a highly 
accurate quantification of the volume of each segment. Studies reporting on regression of the 
sac require the analysis of numerous variables. For example, the iliac arteries are rarely 
included in the analysis factors for aneurysmal regression. However, they can be the source of 
complications, which compromise regression as a consequence of a preoperative pathology. 
For this reason, we carried out an exhaustive analysis of all of the preoperative anatomic 
parameters. We modified some of the risk scores described in the reporting standards since 
we wished, for example, to unite all of the variables relating to iliac arteries into one single 
anatomic severity score. Two multivariate analyses were thus necessary, since it was our aim 
not only to accurately identify each individual factor, but also to evaluate the overall anatomic 
zone (aortic neck, AAA and iliac arteries) on a global basis, i.e. through the use of a single 
score.  
In this study, age appears to have a non negligible influence on regression of the aneurysmal 
sac. In most studies, this outcome has not been clearly identified as a factor influencing 
regression. Quite commonly, various authors have tried to identify factors influencing the 
progression of the sac following EVAR, and have found an advanced age to be a risk factor, 
in particular in the meta-analysis of Schanzer et al.
19
 in which patients having an age > 80 
years is one of these factors, and is well correlated with the reporting standard severity grade
15
 
(grade 3). The same result was found by Ouriel et al.
20
, who recognized that a lower 
regression rate was found when the patients' age increased. Although the definitions for 
regression can vary, Houballah et al.
21
 found a lower mean age in the group of patients who 
presented with sac regression. Since age was not found to be a predictive factor for regression 
in all studies, we tried to corroborate our results using survival analyses, which appear to be 
the most appropriate approach when the history of each patient is different. It is nevertheless 
important to note that the highest regression rate is not found in the patients belonging to 
grade 0. However, a small number of patients (6) in our study had this grade. Moreover, 
analysis of survival age reveals a difference, especially between grades 1 and 3 and we found 
a significant correlation between age and the postoperative evolution of the AAA diameter. 
This outcome thus suggests that there is a relationship between age and postoperative sac 
evolution, in agreement in agreement with the findings of other authors
19-21
.  An explanation 
for the influence of age on regression could lie in the fact that arterial compliance decreases 
with age
22
, and that calcifications are partly responsible
23
. Furthermore, young patients often 
have less arterial calcification
24
 such that, although it has not been scientifically demonstrated, 
it would be reasonable to expect that the regression capacity of an aneurysm is partly 
dependent on these factors, in the absence of any endoleaks. Although we did not quantify 
calcifications of the AAA itself, it has been shown that the degree of calcification of an AAA 
is a predictive factor of the natural history of small AAAs
25
, which again supports the possible 
role of calcifications in the sac regression process. In addition, in our study calcification is 
one of the significant predictive factors for regression, in univariate and multivariate analysis. 
However, one of the limitations of this study is that of quantifying calcifications. Although we 
adhered to the reporting standards, it is clear that the evaluation of calcification, based simply 
on the analysis of four quadrants from a transverse cut, is insufficient for correct evaluation of 
the degree of calcification in a given anatomic zone. Segmentation algorithms with better 
performance, which would not be particularly useful in routine applications, such as EVAR 
planning, should nevertheless be implemented into the software, in order to provide more 
accurate quantification. 
Concerning the anatomic factors assessed in our study, it is not surprising that in the 
multivariate analyses, we systematically found the aortic neck to be a significant variable. 
Here, the absence of calcifications (grade 0) appears to have a particular influence on sac 
regression. Their presence clearly compromises the proximal attachment zone and increases 
the risk of an endoleak as shown by the comparison between patients with or without a type Ia 
endoleak during follow-up. Although the other parameters related to the aortic neck are non 
significant (except for the case of thrombus, in univariate analysis), it is interesting to observe 
that the aortic neck score is significant. Taking all factors into account appears to be a more 
strongly influential element on sac regression, than each parameter considered individually. 
This is also true and largely accepted in the case of the risk of postoperative complications
26
. 
Although it is not the case in the present study, in most studies the length of the aortic neck is 
the factor having the greatest influence on postoperative changes in diameter
9, 14, 19
. The 
presence of thrombus on the aortic neck has also been identified by other authors as being a 
factor contributing to non-regression
13, 27
. The indication for an EVAR on complex aortic 
necks, using current endoprostheses, thus increases the risk of non-regression, such that the 
manufacturers' instructions must be adhered to, if a satisfactory result is to be achieved. 
Schanzer et al.
 (19)
 have revealed a significant rate of disregard for these indications, which 
could explain the high rate of aortic neck growth observed in their study, which is the largest 
existing meta-analysis on this subject.  
The size and thrombus of an AAA have also been analyzed in several studies, with differing 
results. In our study, the size and the thrombus of the AAA do not appear to have an influence 
on its regression. On the one hand, some authors
11, 28
 did not find any influence of 
preoperative diameter on sac regression, and on the other hand, it appears that the larger the 
aneurysm, the less it regresses
21, 29
. Finally, Greenberg et al.
10
 found that the AAAs which are 
the largest at the surface have the greatest regression in absolute and relative terms. 
Concerning aneurysmal thrombosis, Yeung et al.
27
 found that the absence of preoperative 
thrombosis, associated with the absence of an early endoleak, was a good indicator for sac 
regression. However, when there is no thrombus in the sac, the IMA as well as a high number 
of lumbar arteries are often permeable, which is a factor for a type II endoleak
30, 31
. In our 
study, the permeability of the IMA appears to have an influence on sac regression in 
univariate analysis and on the occurrence of a type II endoleak. Preoperative embolization 
could then be considered as a complementary intervention, which would increase the rate of 
sac regression following EVAR. However, Nevala et al.
10
 have shown that there was a 
decrease in the rate of an early type 2 endoleak, but no increase in sac regression. In the 
present study, we find that patients with a permeable IMA have a lower probability of having 
a sac regression due to a greater probability of developing a type II endoleak whereas when 
aneurysm sac collaterals were graded according to the reporting standard, no difference is 
observed. This result can be explained by the fact that the majority of our patients was classed 
in severity grades 2 or 3, which may highlight one of the limitations of this grading system, 
indicating that it could be too severe for the description of the AAA collaterals. Finally, as in 
our own study, Blankenstein et al.
33
 did not find an influence of preoperative aneurysmal 
thrombus on sac regression. 
The last point, which has also been studied by several authors, is the influence of the 
endografts. Here, we were not able to demonstrate any difference between endografts, 
probably because the vast majority of implanted devices are represented by two different 
endografts models (Talent and Zenith). Indeed, very few first generation endografts were 
implanted, since most of our unit's activities began at the time when these two models were 
available on the market. Although Ouriel et al.
7
 found very significant differences between 
endografts in their series, the Talent and Zenith models had the same regression rate. 
Greenberg et al.
10
 found higher regression rates with the Zenith, as compared to the Ancure 
and Excluder models. Bertges et al.
11
 found the highest regression rates with the Talent 
model, at 1 and 2 years, as compared to the Ancure, Excluder and Aneurx models. The Talent 
and the Zenith are thus likely to be the endografts having the best regression rates or having 
no statistically significant difference in our series. This result was also found by Badger et al. 
who compared these two endografts
34
. 
Several limitations can be found in our series. It is a retrospective study, and a certain number 
of operated patients could not be included in our analyses, which constitutes a selection bias. 
In addition, the follow-up dates were not the same for all of the patients, which is the reason 
for which we conducted survival analyses rather than logistical regressions at a date point. 
Finally, the AAA diameter measurement method and the threshold for defining regression are 
also subjects of debate. Wever et al.
 35
 have shown that volumetry was more appropriate for 
the follow-up of EVARs, but when the maximum diameter varies by ± 6%, the correlation 
with volume is correct. By choosing a threshold of 5 mm
2, 15, 18
 on the aneurysm, the mean 
diameter of which was 55.9 mm in our series, a variation of at least 10% is found, which is 
considered by several authors to be a reliable figure. In addition, volumetry is not a routine 
measurement and requires time and the availability of an appropriate workstation. Houballah 
et al.
21
 have proposed another definition for shrinkage, with the aim of identifying it as a 
sensitive and specific marker for successful treatment, on the basis of this definition. 
CONCLUSION 
The use of the reporting standard and the anatomic severity grades provides a reliable tool for 
the description of objective anatomic criteria before EVAR and in our opinion should be more 
widely used in studies dealing with EVAR. In the present study, age seems to be influent on 
aneurysmal sac evolution. Younger patients could have a higher rate of aneurysmal sac 
regression than other patients because of a lower rate of endoleaks. The quality of the aortic 
neck, in particular the absence of calcification, appears to be a determinant factor. The best 
long-term EVAR results probably occur in this population of relatively young patients having 
a good anatomy. New endoprostheses (Endurant, Medtronic and Zenith LP, Cook), which are 
designed for more complex anatomies, will perhaps allow such results to be obtained.  
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Table 1. Definition of each anatomic grade according to the reporting standard and the severity scores 
used  
 Anatomic severity grades 
Attribute 0=Absent 1=Mild 2=Moderate 3=Severe 
Aortic Neck 
Length (L1), mm L1>25 15<L1<25  10<L1<15  L1<10 
Diameter (D1), mm D1<24  24<D1<26  26<D1<28  D1>28  
Angle (A1), ° A1>150 150< A1<135 135< A1<120 A1<120 
Calcifications (Ca1), % Ca1<25 25 <Ca1<50 Ca1>50  
Thrombus (Th1), % Th1<25 25 <Th1<50 Th1>50  
Aortic Neck Severity Score (/15) = L1+D1+A1+Ca1+Th1 grades 
Aneurysm 
Tortuosity index (T1) T1<1.05 1.05<T1<1.15 1.15<T1<1.2 T1>1.2 
Aortic angle (A2), ° 160<A2<180 140<A2<159 120<A2<139 A2<120 
Thrombus (Th2), % 0 Th2<25 25<Th2<50 Th2>50 
Aortic branches (AB) None 1 lumbar/IMA 2 vessels<4 mm 2 vessels >4 mm 
Aneurysm Severity Score (/12) =T1+A2+Th2+AB grades 
Iliac artery 
Calcification (Ca2), % None Ca2<25 25< Ca2<50 Ca2>50 
Thrombus (Th3), % Th3<25 25<Th3<50 Th3>50  
Length (L2), mm L2<30 20< L2<30 10< L2<20 L2<10 
Diameter (D2), mm D2<12.5 12.5< D2<14.4 14.5< D2<17 D2>17 
Tortuosity index (T2) T2<1.25 1.25<T2<1.5 1.5<T2<1.6 T2>1.6 
Iliac angle (A3), ° 160<A3<180 121<A3<159 90<A3<120 <90 
Access diameter (AD), mm AD>10 8<AD<10 7<AD<8 AD<7 
Iliac artery Severity Score (/21) =Ca2+Th3+L2+D2+T2+A3+AD grades 
IMA, inferior mesenteric artery  
 
Table 2. IVS/ISCVS medical comorbidity grading system 
Major components 
Cardiac status 
Grade 0 Asymptomatic, with normal electrocardiogram 
Grade 1 Asymptomatic but with either remote myocardial infarction by history (6 months), occult 
myocardial infarction by electrocardiogram, or fixed defect on dipyridamole thallium or 
similar scan 
Grade 2 Any one of the following: stable angina, no angina but significant reversible perfusion 
defect on dipyridamole thallium scan, significant silent ischemia (1% of time) on Holter 
monitoring, ejection fraction 25% to 45%, controlled ectopy or asymptomatic 
arrhythmia, or history of congestive heart failure that is now well compensated 
Grade 3 Any one of the following: unstable angina, symptomatic or poorly controlled 
ectopy/arrhythmia (chronic/recurrent), poorly compensated or recurrent congestive heart 
failure, ejection fraction less than 25%, myocardial infarction within 6 months 
Pulmonary status 
Grade 0 Asymptomatic, normal chest radiograph, pulmonary function tests within 20% of 
predicted 
Grade 1 Asymptomatic or mild dyspnea on exertion, mild chronic parenchymal radiograph 
changes, pulmonary function tests 65% to 80% of predicted 
Grade 2 Between 1 and 3 
Grade 3 Vital capacity less than 1.85 L, FEV1 less than 1.2 L or less than 35% of predicted, 
maximal voluntary ventilation less than 50% of predicted, PCO2 greater than 45 mm Hg, 
supplemental oxygen use medically necessary, or pulmonary hypertension 
Renal status 
Grade 0 No known renal disease, normal serum creatinine level 
Grade 1 Moderately elevated creatinine level, as high as 2.4 mg/dL 
Grade 2 Creatinine level, 2.5 to 5.9 mg/dL 
Grade 3 Creatinine level greater than 6.0 mg/dL, or on dialysis or with kidney transplant 
Minor components 
Hypertension 
Grade 0 None (cutoff point, diastolic pressure usually lower than 90 mm Hg) 
Grade 1 Controlled (cutoff point, diastolic pressure usually lower than 90 mm Hg) with single 
drug 
Grade 2 Controlled with two drugs 
Grade 3 Requires more than two drugs or uncontrolled 
Age 
Grade 0 <55 years 
Grade 1 55-69 years 
Grade 2 70-79 years 
Grade 3 >80 years 
Table 3. The clinical and anatomical variables (graded according to the reporting standard) are 
compared between group A and B by an univariate analysis (log-rank test). 
 Grade 0 Grade 1 Grade 2 Grade 3  
 
n/N 
Mean ± 
SD* 
n/N 
Mean ± 
SD* 
n/N 
Mean ± 
SD* 
n/N 
Mean ± 
SD* 
P 
Medical comorbidities 
Cardiac status 11/29 13 ± 8 18/44 14 ± 8 21/56 15 ± 11 16/35 20 ± 11 .97 
Pulmonary status 7/29 14 ± 6 37/76 14 ± 9 18/48 18 ± 6 4/11 17 ± 8 .36 
Renal status 36/92 17 ± 8 21/46 16 ± 7 8/24 19 ± 7 1/2 18  .68 
Hypertension 7/16 17 ± 9 10/28 19 ± 8 37/96 16 ± 8 12/24 18 ± 9 .78 
Age 2/6 12 21/36 15 ± 7 30/66 16 ± 11 13/56 18 ± 9 .005 
Anatomic factors 
Aortic neck (N=164) 
Diameter 36/87 13 ± 7 16/33 15 ± 6 9/32 16 ± 4 5/12 17 ± 3 .41 
Angle 30/70 17 ± 11 19/57 16 ± 9 12/28 17 ± 8 5/9 15 ± 4 .72 
Length 26/68 12 ± 11 21/51 13 ± 11 19/45 18 ± 6 - - .51 
Thrombus 39/79 14 ± 8 14/38 15 ± 7 10/34 14 ± 7 3/13 15 ± 3 .02 
Calcifications 48/94 14 ± 7 14/41 17 ± 6 3/26 19 ± 7 1/3 18  .003 
Aneurysm (N=164) 
Tortuosity 21/39 16 ± 6 35/103 17 ± 9 6/12 16 ± 7 4/10 19 ± 2 .31 
Angle 11/26 13 ± 6 28/62 17 ± 9 23/65 17 ± 5 4/11 18 ± 3 .45 
Thrombus 3/9 17 ± 9 11/25 16 ± 7 29/49 19 ± 2 23/81 18 ± 3 .20 
Aortic branches - - 7/15 18 ± 6 34/75 17 ± 5 25/73 16 ± 2 .29 
Iliac arteries (N=327) 
Diameter 48/84 12 ± 8 22/91 15 ± 6 33/91 19 ± 7 29/60 17 ± 8 .44 
Length 131/325 16 ± 13 1/2 18  - - - - .81 
Angle 0/3 - 69/154 15 ± 8 61/137 16 ± 6 11/33 18 ± 7 .81 
Tortuosity 20/38 17 ± 8 22/54 14 ± 7 2/13 19  1/5 18  .35 
Thrombus 69/141 11 ± 7 42/128 16 ± 8 11/48 17 ± 8 5/10 16 ± 3 .02 
Calcifications 53/94 15 ± 8 59/147 16 ± 8 20/77 15 ± 8 0/10 - .001 
Minimum 10/35 13 ± 11 82/183 17 ± 10 23/74 15 ± 7 18/35 16 ± 9 .48 
n/N, number with sac regression/total  
*delay (in months) of the occurrence of the regression>5mm  
 
 
 
 
 
Table 4. Comparison of the anatomic severity score between group A and B. 
 Total population (n=164) Group A (n=66) Group B (n=98) P  
Aortic neck severity 
score (/15) 
4 ± 2.4 3.5 ± 2.3 4.4 ± 2.5 0.02 
Aneurysm severity score 
(/12) 
6.9 ± 1.9 6.6 ± 1.8 7.1 ± 1.9 0.06 
Iliac artery severity 
score (/21) 
7.2 ± 2.5 6.5 ± 2,1 7.7 ± 2.3 0.002 
Table 5. Endoprosthesis implanted in each group. 
 Group A Group B 
Talent (Medtronic) 28 (42%) 62 (63%) 
Zenith (Cook) 31 (47%) 25 (26%) 
Excluder (Gore) 4 (6%) 6 (6%) 
Anaconda (Vascutek) 3 (5%) 1 (1%) 
Vanguard (Boston scientific) 0 1 (1%) 
Endologix (Bard) 0 1 (1%) 
Aneurx (Medtronic) 0 2 (2%) 
P value* 0.40 
*from the Fischer exact test
Table 6. Rates of endoleaks  in group A and B (log-rank-test). 
 
 Total (n=164) Group A (n=66) Group B (n=98) P  
Type Ia endoleak 13 (7.9%) 1 (1.5%) 12 (12.2%) 0.012 
Type Ib endoleak 7 (4.3%) 0 7 (4.3%) 0.032 
Type II endoleak 33 (20.1%) 4 (6.1%) 29 (29.6%) <0.001 
 
Table 7. Comparison of the anatomic severity scores between patients with or without an endoleak 
during follow-up 
 Endoleak No endoleak P  
Aortic neck severity score (/15) –Type 
Ia endoleak (n=10) 
6.9 ± 2.6 3.8 ± 2.3 <0.0001 
Aneurysm severity score (/12)-Type II 
endoleak (n=33) 
7.2 ± 1.7 6.8 ± 1.8 0.33 
Iliac artery severity score (/21)-Type Ib 
endoleak (n=7) 
9.3 ± 2.2 7.1 ± 2.3 0.001 
Table 8. The anatomical variables are compared between patients with or without an endoleak during 
follow-up by an univariate analysis (log-rank test). 
 Grade 0 Grade 1 Grade 2 Grade 3  
 
n/N 
Mean ± 
SD* 
n/N 
Mean ± 
SD* 
n/N 
Mean ± 
SD* 
n/N 
Mean ± 
SD* 
P 
Aortic neck-Type Ia endoleak 
Diameter 0/87 - 1/33 12 8/32 54 ± 20 4/12 36 ± 24 .10 
Angle 0/70  5/57 31 ± 30 3/28 20 ± 12 5/9 25 ± 7 .10 
Length 2/68 24  5/51 36 ± 11 6/45 44 ± 35 - - .08 
Thrombus 0/79 - 2/38 41  5/34 48 ± 12 6/13 22 ± 7 .01 
Calcifications 0/94 - 0/41 - 11/26 19 ± 7 2/3 18  .01 
Aneurysm-Type II endoleak 
Tortuosity 11/39 5 ± 6 15/103 6 ± 8 3/12 6 ± 7 4/10 6 ± 4 .75 
Angle 4/26 5 ± 9 12/62 6 ± 4 13/65 7 ± 10 4/11 4 ± 4 .44 
Thrombus 3/9 3 ± 3 6/25 6 ± 7 7/49 4 ± 4 17/81 7 ± 9 .25 
Aortic branches - - 2/15 3 15/75 3 ± 4 16/73 7 ± 9 .21 
Iliac arteries-Type Ib endoleak 
Diameter 1/84 21 1/91 28 2/91 51 3/60 24 ± 17 .14 
Length 6/325 34 ± 27 1/2 28 - - - - .06 
Angle 0/3 - 1/154 48 2/137 21 4/33 18 ± 7 .01 
Tortuosity 0/38 - 2/54 24  2/13 19  3/5 18 ± 8 <0.001 
Thrombus 0/141 - 1/128 36 5/48 28 ± 8 1/10 48 .02 
Calcifications 0/94 - 0/147 - 5/77 31 ± 16 2/10 29  <0.001 
Minimum 1/35 21  3/183 26 ± 12 2/74 21 1/35 37 .26 
n/N, number with endoleak/total  
*Delay (in months) of the occurrence of the endoleak
 Figures 
Figure 1. Aorto-iliac mesurements with Endosize: iliac tortuosity index measurement. 
 
 
Figure 2. Proportion of patients with aneurysm shrinkage (>5mm) according to the grading age 
defined in the reporting standard. 
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Figure 3. Correlation between age and postoperative variation of the AAA diameter 
 
 
 
 
 
